Sorry to keep banging on about this, but I went to the SR users forum yesterday, and it is quite clear that nothing is safe.
Although "Diamond operations and commissioning" & "ESRF upgrades" are in the high-priority category, the expanded PALS prioritisation document includes this in the discussion of Diamond Phase I: "...redeploying resources where possible to ensure that all Phase I beam-lines are operational" and the ESRF upgrade: "in the current financial climate even those facilities considered to be a high priority may not receive all of the funding that they desire" You don't have to be as cynical as me to see the underlying threat in these. The development of Diamond -(Phases II and III) is in the medium-priority category. Should phases II and III be cut, then Diamond will be effectively frozen in its present state. That means no more beam-lines and no development of the current ones. Please respond to the consultation document, note the example of the well-orgainsed astronomy lobby and exploit any contact you have with the media to emphasise the importance of these facilities in basic biomedical science etc., lobby your MP, etc. etc. as soon as possible. Peter PS Overseas subsribers, sorry to fill up you mailboxes, please note that he consultaion process will accept comment from outside the UK as well, should you feel able to support us. Peter Moody 1/56 Henry Wellcome Laboratories University of Leicester Lancaster Road Leicester LE1 9HN UK tel. (0)116 229 7097 fax. (0)116 229 7084 ________________________________ From: CCP4 bulletin board [EMAIL PROTECTED] On Behalf Of Moody, Dr P.C.E. [EMAIL PROTECTED] Sent: 06 March 2008 17:49 To: [email protected] Subject: [ccp4bb] STFC Consultation exercise on programmatic review Following my earlier email, please note that further information has just been added to the site (http://www.scitech.ac.uk/stfcconsultation/comment.aspx). This includes a brief explanation about what was considered under each heading on the PALS prioritisation list. Peter Peter Moody 1/56 Henry Wellcome Laboratories University of Leicester Lancaster Road Leicester LE1 9HN UK tel. (0)116 229 7097 fax. (0)116 229 7084
